CA Stock MarketDetailed Quotes

NRX NurExone Biologic Inc

Watchlist
  • 0.590
  • +0.060+11.32%
15min DelayMarket Closed Aug 15 16:00 ET
39.59MMarket Cap-5363P/E (TTM)

About NurExone Biologic Inc Company

NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.

Company Profile

SymbolNRX
Company NameNurExone Biologic Inc
Founded2011
MarketTSX
Employees16
Fiscal Year Ends12-31
Address1 Adelaide St. East Suite 801
CityToronto
CountryCAN
Zip CodeM5C 2V9

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lior Shaltiel, PhD
  • Chief Executive Officer and Director
  • --
  • Eran Ovadya
  • Chief Financial Officer
  • --
  • Yoram Drucker
  • Chairman of the Board and Vice President, Strategic Development
  • --
  • Oded Orgil
  • Director
  • --
  • James Richardson
  • Independent Director
  • --
  • Gadi Riesenfeld
  • Independent Director
  • --
Heat List
CA
Overall
Symbol
Latest Price
% Chg